Clinical Trial Update: Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee [NA]

View source ↗

Summary

A completed clinical trial comparing flavocoxid (Limbrel) to naproxen in subjects with moderate to severe knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Limbrel (flavocoxid)
• Naproxen (Naproxen)

Snippet

Sponsor: Primus Pharmaceuticals | Conditions: Osteoarthritis | NA | Status: COMPLETED